Thus, the dysregulation of leptin actions, e.g., changes in leptin receptor expression in adipose tissue, may influence obesity and other metabolic disorders development, such as insulin resistance and type II diabetes [1, 11]. This evidence concerns the gene LEPR and metabolic disease.